Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Drug Resistance

  Free Subscription


Articles published in Int J Antimicrob Agents

Retrieve available abstracts of 139 articles:
HTML format
Text format



Single Articles


    April 2017
  1. CHANG YT, Coombs G, Ling T, Balaji V, et al
    Epidemiology and trends in the antibiotic susceptibilities of Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region, 2010-2013.
    Int J Antimicrob Agents. 2017 Apr 20. pii: S0924-8579(17)30121.
    PubMed     Text format     Abstract available


  2. KRAPP F, Grant JL, Sutton SH, Ozer EA, et al
    Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation.
    Int J Antimicrob Agents. 2017 Apr 4. pii: S0924-8579(17)30105.
    PubMed     Text format     Abstract available


  3. BI Z, Berglund B, Sun Q, Nilsson M, et al
    Prevalence of the mcr-1 colistin resistance gene in extended-spectrum beta-lactamase-producing Escherichia coli from human faecal samples collected in 2012 in rural villages in Shandong Province, China.
    Int J Antimicrob Agents. 2017;49:493-497.
    PubMed     Text format     Abstract available


  4. MORALES-BARROSO I, Lopez-Cerero L, Molina J, Bellido M, et al
    Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.
    Int J Antimicrob Agents. 2017;49:498-502.
    PubMed     Text format     Abstract available


    March 2017
  5. SYDENHAM TV, Jensen BH, Petersen AM, Krogfelt KA, et al
    Antimicrobial resistance in the Bacteroides fragilis group in faecal microbiota from healthy Danish children.
    Int J Antimicrob Agents. 2017 Mar 31. pii: S0924-8579(17)30097.
    PubMed     Text format     Abstract available


  6. FLOKAS ME, Karageorgos SA, Detsis M, Alevizakos M, et al
    Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2017 Mar 20. pii: S0924-8579(17)30086.
    PubMed     Text format     Abstract available


  7. ROCHA IV, das Neves Andrade CA, de Lima Campos T, Rezende AM, et al
    Ciprofloxacin-resistant and extended-spectrum beta-lactamase-producing Escherichia coli ST410 strain carrying the mcr-1 gene associated with bloodstream infection.
    Int J Antimicrob Agents. 2017 Mar 13. pii: S0924-8579(17)30081.
    PubMed     Text format    


  8. PAGANELLI FL, van de Kamer T, Brouwer EC, Leavis HL, et al
    Lipoteichoic acid synthesis inhibition in combination with antibiotics abrogates growth of multidrug-resistant Enterococcus faecium.
    Int J Antimicrob Agents. 2017;49:355-363.
    PubMed     Text format     Abstract available


  9. WEI WJ, Yang HF
    Synergy against extensively drug-resistant Acinetobacter baumannii in vitro by two old antibiotics: colistin and chloramphenicol.
    Int J Antimicrob Agents. 2017;49:321-326.
    PubMed     Text format     Abstract available


  10. RHOUMA M, Letellier A
    Extended-spectrum beta-lactamases, carbapenemases and the mcr-1 gene: is there a historical link?
    Int J Antimicrob Agents. 2017;49:269-271.
    PubMed     Text format     Abstract available


  11. CHEN CY, Tien FM, Sheng WH, Huang SY, et al
    Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008-2013.
    Int J Antimicrob Agents. 2017;49:272-281.
    PubMed     Text format     Abstract available


    February 2017
  12. LAI CC, Chuang YC, Chen CC, Tang HJ, et al
    Coexistence of MCR-1 and NDM-9 in a clinical carbapenem-resistant Escherichia coli isolate.
    Int J Antimicrob Agents. 2017 Feb 17. pii: S0924-8579(17)30042.
    PubMed     Text format    


  13. TORPDAHL M, Hasman H, Litrup E, Skov RL, et al
    Detection of mcr-1-encoding plasmid-mediated colistin-resistant Salmonella isolates from human infection in Denmark.
    Int J Antimicrob Agents. 2017;49:261-262.
    PubMed     Text format    


  14. SHARMA R, Patel S, Abboud C, Diep J, et al
    Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes.
    Int J Antimicrob Agents. 2017;49:224-232.
    PubMed     Text format     Abstract available


  15. JOHNSON SR, Grad Y, Abrams AJ, Pettus K, et al
    Use of whole-genome sequencing data to analyze 23S rRNA-mediated azithromycin resistance.
    Int J Antimicrob Agents. 2017;49:252-254.
    PubMed     Text format     Abstract available


  16. KOEHLER P, Hamprecht A, Bader O, Bekeredjian-Ding I, et al
    Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.
    Int J Antimicrob Agents. 2017;49:218-223.
    PubMed     Text format     Abstract available


  17. RODRIGUEZ CA, Agudelo M, Zuluaga AF, Vesga O, et al
    In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products.
    Int J Antimicrob Agents. 2017;49:189-197.
    PubMed     Text format     Abstract available


  18. XIPELL M, Bodro M, Marco F, Losno RA, et al
    Clinical experience with ceftazidime/avibactam in patients with severe infections, including meningitis and lung abscesses, caused by extensively drug-resistant Pseudomonas aeruginosa.
    Int J Antimicrob Agents. 2017;49:266-268.
    PubMed     Text format    


  19. VARDAKAS KZ, Falagas ME
    Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2017;49:233-238.
    PubMed     Text format     Abstract available


    January 2017
  20. PULCINI C, Tebano G, Mutters NT, Tacconelli E, et al
    Selective reporting of antibiotic susceptibility test results in European countries: an ESCMID cross-sectional survey.
    Int J Antimicrob Agents. 2017 Jan 10. pii: S0924-8579(17)30007.
    PubMed     Text format     Abstract available


  21. ORTIZ DE LA TABLA V, Ortega A, Bunuel F, Perez-Vazquez M, et al
    Detection of the high-risk clone ST131 of Escherichia coli carrying the colistin resistance gene mcr-1 and causing acute peritonitis.
    Int J Antimicrob Agents. 2017;49:115-116.
    PubMed     Text format    


  22. FERNANDO DM, Chong P, Singh M, Spicer V, et al
    Multi-omics approach to study global changes in a triclosan-resistant mutant strain of Acinetobacter baumannii ATCC 17978.
    Int J Antimicrob Agents. 2017;49:74-80.
    PubMed     Text format     Abstract available


  23. UNGER F, Eisenberg T, Prenger-Berninghoff E, Leidner U, et al
    Imported reptiles as a risk factor for the global distribution of Escherichia coli harbouring the colistin resistance gene mcr-1.
    Int J Antimicrob Agents. 2017;49:122-123.
    PubMed     Text format    


  24. OPOTA O, Diene SM, Bertelli C, Prod'hom G, et al
    Genome of the carbapenemase-producing clinical isolate Elizabethkingia miricola EM_CHUV and comparative genomics with Elizabethkingia meningoseptica and Elizabethkingia anophelis: evidence for intrinsic multidrug resistance trait of emerging pathogens
    Int J Antimicrob Agents. 2017;49:93-97.
    PubMed     Text format     Abstract available


  25. CHOI HJ, Kil MC, Choi JY, Kim SJ, et al
    Characterisation of successive Acinetobacter baumannii isolates from a deceased haemophagocytic lymphohistiocytosis patient.
    Int J Antimicrob Agents. 2017;49:102-106.
    PubMed     Text format     Abstract available


  26. BROWN K, Uwiera RR, Kalmokoff ML, Brooks SP, et al
    Antimicrobial growth promoter use in livestock: a requirement to understand their modes of action to develop effective alternatives.
    Int J Antimicrob Agents. 2017;49:12-24.
    PubMed     Text format     Abstract available


    December 2016
  27. DOMINGUEZ-HERRERA J, Lopez-Rojas R, Smani Y, Labrador-Herrera G, et al
    Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis.
    Int J Antimicrob Agents. 2016;48:661-665.
    PubMed     Text format     Abstract available


  28. OLAITAN AO, Li J
    Emergence of polymyxin resistance in Gram-negative bacteria.
    Int J Antimicrob Agents. 2016;48:581-582.
    PubMed     Text format    


  29. GIAMARELLOU H
    Epidemiology of infections caused by polymyxin-resistant pathogens.
    Int J Antimicrob Agents. 2016;48:614-621.
    PubMed     Text format     Abstract available


  30. GAO Q, Wu S, Huang H, Ni Y, et al
    Toxin profiles, PCR ribotypes and resistance patterns of Clostridium difficile: a multicentre study in China, 2012-2013.
    Int J Antimicrob Agents. 2016;48:736-739.
    PubMed     Text format     Abstract available


  31. CAI J, Wang Y, Schwarz S, Zhang G, et al
    High detection rate of the oxazolidinone resistance gene optrA in Enterococcus faecalis isolated from a Chinese anorectal surgery ward.
    Int J Antimicrob Agents. 2016;48:757-759.
    PubMed     Text format    


  32. YANAT B, Machuca J, Yahia RD, Touati A, et al
    First report of the plasmid-mediated colistin resistance gene mcr-1 in a clinical Escherichia coli isolate in Algeria.
    Int J Antimicrob Agents. 2016;48:760-761.
    PubMed     Text format    


  33. BARON S, Hadjadj L, Rolain JM, Olaitan AO, et al
    Molecular mechanisms of polymyxin resistance: knowns and unknowns.
    Int J Antimicrob Agents. 2016;48:583-591.
    PubMed     Text format     Abstract available


    November 2016
  34. MISCHNIK A, Baumert P, Hamprecht A, Rohde A, et al
    Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
    Int J Antimicrob Agents. 2016 Nov 28. pii: S0924-8579(16)30349.
    PubMed     Text format     Abstract available


  35. GOMEZ-ZORRILLA S, Calatayud L, Juan C, Cabot G, et al
    Understanding the acute inflammatory response to Pseudomonas aeruginosa infection: differences between susceptible and multidrug-resistant strains in a mouse peritonitis model.
    Int J Antimicrob Agents. 2016 Nov 28. pii: S0924-8579(16)30352.
    PubMed     Text format     Abstract available


  36. HWANG D, Kim SM, Kim HJ
    Modelling of tetracycline resistance gene transfer by commensal Escherichia coli food isolates that survived in gastric fluid conditions.
    Int J Antimicrob Agents. 2016 Nov 22. pii: S0924-8579(16)30345.
    PubMed     Text format     Abstract available


  37. GUIGNARD B, Majcherczyk PA, Monachon C, Vouillamoz J, et al
    Muropeptide signature of inhibitors of protein synthesis correlates with beta-lactam synergism against methicillin-resistant Staphylococcus aureus.
    Int J Antimicrob Agents. 2016 Nov 16. pii: S0924-8579(16)30335.
    PubMed     Text format     Abstract available


  38. PERDIGAO J, Maltez F, Machado D, Silva H, et al
    Beyond extensively drug-resistant tuberculosis in Lisbon, Portugal: a case of linezolid resistance acquisition presenting as an iliopsoas abscess.
    Int J Antimicrob Agents. 2016;48:569-570.
    PubMed     Text format    


  39. LANG PM, Jacinto RC, Dal Pizzol TS, Ferreira MB, et al
    Resistance profiles to antimicrobial agents in bacteria isolated from acute endodontic infections: systematic review and meta-analysis.
    Int J Antimicrob Agents. 2016;48:467-474.
    PubMed     Text format     Abstract available


  40. MCNEIL HC, Lean SS, Lim V, Clarke SC, et al
    The state of ESKAPE in Malaysia.
    Int J Antimicrob Agents. 2016;48:578-579.
    PubMed     Text format    


  41. ISNARD C, Fines-Guyon M, Toublet FX, Guerin F, et al
    In vivo emergence of rifampicin resistance by rpoB mutation in Listeria monocytogenes during therapy of prosthetic joint infection.
    Int J Antimicrob Agents. 2016;48:572-574.
    PubMed     Text format    


  42. LIN YT, Huang YW, Huang HH, Yang TC, et al
    In vivo evolution of tigecycline-non-susceptible Klebsiella pneumoniae strains in patients: relationship between virulence and resistance.
    Int J Antimicrob Agents. 2016;48:485-491.
    PubMed     Text format     Abstract available


  43. TSIOUTIS C, Kritsotakis EI, Karageorgos SA, Stratakou S, et al
    Clinical epidemiology, treatment and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients.
    Int J Antimicrob Agents. 2016;48:492-497.
    PubMed     Text format     Abstract available


    October 2016
  44. OVIANO M, Sparbier K, Barba MJ, Kostrzewa M, et al
    Universal protocol for the rapid automated detection of carbapenem-resistant Gram-negative bacilli directly from blood cultures by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF/MS).
    Int J Antimicrob Agents. 2016 Oct 20. pii: S0924-8579(16)30285.
    PubMed     Text format     Abstract available


  45. SINEL C, Jaussaud C, Auzou M, Giard JC, et al
    Mutant prevention concentrations of daptomycin for Enterococcus faecium clinical isolates.
    Int J Antimicrob Agents. 2016;48:449-52.
    PubMed     Text format     Abstract available


  46. BAI L, Hurley D, Li J, Meng Q, et al
    Characterisation of multidrug-resistant Shiga toxin-producing Escherichia coli cultured from pigs in China: co-occurrence of extended-spectrum beta-lactamase- and mcr-1-encoding genes on plasmids.
    Int J Antimicrob Agents. 2016;48:445-8.
    PubMed     Text format     Abstract available


  47. SIMO TCHUINTE PL, Stalder T, Venditti S, Ngandjio A, et al
    Characterisation of class 3 integrons with oxacillinase gene cassettes in hospital sewage and sludge samples from France and Luxembourg.
    Int J Antimicrob Agents. 2016;48:431-4.
    PubMed     Text format     Abstract available


  48. MOHSIN M, Raza S, Roschanski N, Schaufler K, et al
    First description of plasmid-mediated colistin-resistant extended-spectrum beta-lactamase-producing Escherichia coli in a wild migratory bird from Asia.
    Int J Antimicrob Agents. 2016;48:463-4.
    PubMed     Text format    


    September 2016
  49. PIRES J, Bernasconi OJ, Kasraian S, Hilty M, et al
    Intestinal colonisation with extended-spectrum cephalosporin-resistant Escherichia coli in Swiss pets: molecular features, risk factors and transmission with owners.
    Int J Antimicrob Agents. 2016 Sep 20. pii: S0924-8579(16)30238.
    PubMed     Text format    


  50. LENHARD JR, Gall JS, Bulitta JB, Thamlikitkul V, et al
    Comparative pharmacodynamics of four different carbapenems in combination with polymyxin B against carbapenem-resistant Acinetobacter baumannii.
    Int J Antimicrob Agents. 2016 Sep 20. pii: S0924-8579(16)30239.
    PubMed     Text format     Abstract available


  51. COREY GR, Arhin FF, Wikler MA, Sahm DF, et al
    Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureus.
    Int J Antimicrob Agents. 2016 Sep 13. pii: S0924-8579(16)30232.
    PubMed     Text format     Abstract available


  52. BABOUEE FLURY B, Ellington MJ, Hopkins KL, Turton JF, et al
    The differential importance of mutations within AmpD in cephalosporin resistance of Enterobacter aerogenes and Enterobacter cloacae.
    Int J Antimicrob Agents. 2016 Sep 12. pii: S0924-8579(16)30234.
    PubMed     Text format     Abstract available


  53. LIU X, Zhao M, Chen Y, Bian X, et al
    Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model.
    Int J Antimicrob Agents. 2016 Sep 8. pii: S0924-8579(16)30231.
    PubMed     Text format     Abstract available


  54. HAMZE M, Osman M, Achkar M, Mallat H, et al
    Alarming increase in prevalence of Neisseria gonorrhoeae infections associated with a high level of antibiotic resistance in Tripoli, Lebanon.
    Int J Antimicrob Agents. 2016 Sep 7. pii: S0924-8579(16)30226.
    PubMed     Text format    


  55. PAPP JR, Lawrence K, Sharpe S, Mueller J, et al
    In vitro growth of multidrug-resistant Neisseria gonorrhoeae isolates is inhibited by ETX0914, a novel spiropyrimidinetrione.
    Int J Antimicrob Agents. 2016;48:328-30.
    PubMed     Text format     Abstract available


  56. WANG R, Li J, Kan B
    Sequences of a co-existing SXT element, a chromosomal integron (CI) and an IncA/C plasmid and their roles in multidrug resistance in a Vibrio cholerae O1 El Tor strain.
    Int J Antimicrob Agents. 2016;48:305-9.
    PubMed     Text format     Abstract available


  57. KUTI JL, Ghazi IM, Quintiliani R Jr, Shore E, et al
    Treatment of multidrug-resistant Pseudomonas aeruginosa with ceftolozane/tazobactam in a critically ill patient receiving continuous venovenous haemodiafiltration.
    Int J Antimicrob Agents. 2016;48:342-3.
    PubMed     Text format    


  58. RAO GG, Ly NS, Diep J, Forrest A, et al
    Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii.
    Int J Antimicrob Agents. 2016;48:331-6.
    PubMed     Text format     Abstract available


  59. HUANG SF, Chang JS, Sheu CC, Liu YT, et al
    An antibiotic decision-making tool for patients with pneumonia admitted to a medical intensive care unit.
    Int J Antimicrob Agents. 2016;48:286-91.
    PubMed     Text format     Abstract available


    August 2016
  60. GAYMARD A, Pichon M, Degaud M, Tasse J, et al
    Methicillin-resistant Staphylococcus aureus in the environment of public transport: data from the metropolitan network in Lyon, France.
    Int J Antimicrob Agents. 2016 Aug 17. pii: S0924-8579(16)30208.
    PubMed     Text format     Abstract available


  61. MARINO A, Blanco AR, Ginestra G, Nostro A, et al
    Ex vivo efficacy of gemifloxacin in experimental keratitis induced by methicillin-resistant Staphylococcus aureus.
    Int J Antimicrob Agents. 2016 Aug 11. pii: S0924-8579(16)30201.
    PubMed     Text format     Abstract available


  62. CHOI IS, Lee YJ, Wi YM, Kwan BS, et al
    Predictors of mortality in patients with extensively drug-resistant Acinetobacter baumannii pneumonia receiving colistin therapy.
    Int J Antimicrob Agents. 2016;48:175-80.
    PubMed     Text format     Abstract available


  63. SOLHEIM M, Bohlin J, Ulstad CR, Schau Slettemeas J, et al
    Plasmid-mediated colistin-resistant Escherichia coli detected from 2014 in Norway.
    Int J Antimicrob Agents. 2016;48:227-8.
    PubMed     Text format    


  64. COURT R, Gordon M, Cohen K, Stewart A, et al
    Random lopinavir concentrations predict resistance on lopinavir-based antiretroviral therapy.
    Int J Antimicrob Agents. 2016;48:158-62.
    PubMed     Text format     Abstract available


  65. SADER HS, Castanheira M, Farrell DJ, Flamm RK, et al
    Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011-2014).
    Int J Antimicrob Agents. 2016;48:144-50.
    PubMed     Text format     Abstract available


  66. RHOUMA M, Beaudry F, Letellier A
    Resistance to colistin: what is the fate for this antibiotic in pig production?
    Int J Antimicrob Agents. 2016;48:119-26.
    PubMed     Text format     Abstract available


    July 2016
  67. QUEENAN K, Hasler B, Rushton J
    A One Health approach to antimicrobial resistance surveillance: is there a business case for it?
    Int J Antimicrob Agents. 2016 Jul 25. pii: S0924-8579(16)30183.
    PubMed     Text format     Abstract available


  68. ZHAO M, Liang L, Ji L, Chen D, et al
    Similar efficacy and safety of daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bloodstream infections: a meta-analysis.
    Int J Antimicrob Agents. 2016 Jul 19. pii: S0924-8579(16)30166.
    PubMed     Text format     Abstract available


  69. DIMITRIADIS P, Protonotariou E, Varlamis S, Poulou A, et al
    Comparative evaluation of minocycline susceptibility testing methods in carbapenem-resistant Acinetobacter baumannii.
    Int J Antimicrob Agents. 2016 Jul 7. pii: S0924-8579(16)30155.
    PubMed     Text format     Abstract available


  70. POURNARAS S, Koumaki V, Spanakis N, Gennimata V, et al
    Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance.
    Int J Antimicrob Agents. 2016;48:11-8.
    PubMed     Text format     Abstract available


  71. PAVEZ M, Vieira C, de Araujo MR, Cerda A, et al
    Molecular mechanisms of membrane impermeability in clinical isolates of Enterobacteriaceae exposed to imipenem selective pressure.
    Int J Antimicrob Agents. 2016;48:78-85.
    PubMed     Text format     Abstract available


  72. KUO HY, Hsu PJ, Chen JY, Liao PC, et al
    Clonal spread of blaOXA-72-carrying Acinetobacter baumannii sequence type 512 in Taiwan.
    Int J Antimicrob Agents. 2016;48:111-3.
    PubMed     Text format     Abstract available


  73. HIJAZI K, Mukhopadhya I, Abbott F, Milne K, et al
    Susceptibility to chlorhexidine amongst multidrug-resistant clinical isolates of Staphylococcus epidermidis from bloodstream infections.
    Int J Antimicrob Agents. 2016;48:86-90.
    PubMed     Text format     Abstract available


  74. MATHLOUTHI N, El Salabi AA, Ben Jomaa-Jemili M, Bakour S, et al
    Early detection of metallo-beta-lactamase NDM-1- and OXA-23 carbapenemase-producing Acinetobacter baumannii in Libyan hospitals.
    Int J Antimicrob Agents. 2016;48:46-50.
    PubMed     Text format     Abstract available


    June 2016
  75. SUBIRATS J, Sanchez-Melsio A, Borrego CM, Balcazar JL, et al
    Metagenomic analysis reveals that bacteriophages are reservoirs of antibiotic resistance genes.
    Int J Antimicrob Agents. 2016 Jun 3. pii: S0924-8579(16)30120.
    PubMed     Text format     Abstract available


  76. JAHANBAKHSH S, Smith MG, Kohan-Ghadr HR, Letellier A, et al
    Dynamics of extended-spectrum cephalosporin resistance in pathogenic Escherichia coli isolated from diseased pigs in Quebec, Canada.
    Int J Antimicrob Agents. 2016 Jun 1. pii: S0924-8579(16)30118.
    PubMed     Text format     Abstract available


  77. DAVIDO B, Bouchand F, Calin R, Makhloufi S, et al
    High rates of off-label use in antibiotic prescriptions in a context of dramatic resistance increase: a prospective study in a tertiary hospital.
    Int J Antimicrob Agents. 2016;47:490-4.
    PubMed     Text format     Abstract available


  78. YU CY, Ang GY, Chin PS, Ngeow YF, et al
    Emergence of mcr-1-mediated colistin resistance in Escherichia coli in Malaysia.
    Int J Antimicrob Agents. 2016;47:504-5.
    PubMed     Text format    


  79. LOPEZ-ROJAS R, Garcia-Quintanilla M, Labrador-Herrera G, Pachon J, et al
    Impaired growth under iron-limiting conditions associated with the acquisition of colistin resistance in Acinetobacter baumannii.
    Int J Antimicrob Agents. 2016;47:473-7.
    PubMed     Text format     Abstract available


  80. FREITAS AR, Novais C, Read A, Alves V, et al
    Co-infection with three linezolid-resistant Enterococcus faecium ST117 strain variants: what are we missing in diagnosis?
    Int J Antimicrob Agents. 2016;47:500-1.
    PubMed     Text format    


    May 2016
  81. FALGENHAUER L, Imirzalioglu C, Ghosh H, Gwozdzinski K, et al
    Circulation of clonal populations of fluoroquinolone-resistant CTX-M-15-producing Escherichia coli ST410 in humans and animals in Germany.
    Int J Antimicrob Agents. 2016 May 12. pii: S0924-8579(16)30086.
    PubMed     Text format     Abstract available


  82. BANERJEE S, Sundeep S, Sarma J, Oswald T, et al
    Assume nothing! Staphylococcus aureus resistance to daptomycin may occur in patients not previously exposed to daptomycin or glycopeptides.
    Int J Antimicrob Agents. 2016;47:418-9.
    PubMed     Text format    


  83. CAVALIE L, Mantion B, Fayet O, Prere MF, et al
    blaNDM-1-positive Citrobacter sedlakii: emergence after horizontal gene transfer from Klebsiella pneumoniae in the human intestinal tract.
    Int J Antimicrob Agents. 2016;47:411-3.
    PubMed     Text format    


  84. KHALIFA HO, Ahmed AM, Oreiby AF, Eid AM, et al
    Characterisation of the plasmid-mediated colistin resistance gene mcr-1 in Escherichia coli isolated from animals in Egypt.
    Int J Antimicrob Agents. 2016;47:413-4.
    PubMed     Text format    


  85. TENG JC, Lingaratnam SM, Trubiano JA, Thursky KA, et al
    Oral pristinamycin for the treatment of resistant Gram-positive infections in patients with cancer: Evaluation of clinical outcomes.
    Int J Antimicrob Agents. 2016;47:391-6.
    PubMed     Text format     Abstract available


  86. GOMEZ-ZORRILLA S, Juan C, Cabot G, Camoez M, et al
    Impact of multidrug resistance on the pathogenicity of Pseudomonas aeruginosa: in vitro and in vivo studies.
    Int J Antimicrob Agents. 2016;47:368-74.
    PubMed     Text format     Abstract available


  87. MENEGUCCI TC, Albiero J, Migliorini LB, Alves JL, et al
    Strategies for the treatment of polymyxin B-resistant Acinetobacter baumannii infections.
    Int J Antimicrob Agents. 2016;47:380-5.
    PubMed     Text format     Abstract available


    April 2016
  88. MAHAMAT A, Bertrand X, Moreau B, Hommel D, et al
    Clinical epidemiology and resistance mechanisms of carbapenem-resistant Acinetobacter baumannii, French Guiana, 2008-2014.
    Int J Antimicrob Agents. 2016 Apr 25. pii: S0924-8579(16)30052.
    PubMed     Text format     Abstract available


  89. ABBOUD CS, Monteiro J, Stryjewski ME, Zandonadi EC, et al
    Post-surgical mediastinitis due to carbapenem-resistant Enterobacteriaceae: Clinical, epidemiological and survival characteristics.
    Int J Antimicrob Agents. 2016 Apr 6. pii: S0924-8579(16)30046.
    PubMed     Text format     Abstract available


  90. KANAFANI ZA, Kmeid J, Nawar T, Assaf SM, et al
    Retrospective case series of infections caused by carbapenem-resistant Enterobacteriaceae at a tertiary care centre in Lebanon.
    Int J Antimicrob Agents. 2016 Apr 2. pii: S0924-8579(16)30042.
    PubMed     Text format    


  91. RAOULT D
    Alice's living croquet theory.
    Int J Antimicrob Agents. 2016;47:249.
    PubMed     Text format    


  92. LOB SH, Hoban DJ, Sahm DF, Badal RE, et al
    Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii.
    Int J Antimicrob Agents. 2016;47:317-23.
    PubMed     Text format     Abstract available


  93. LI X, Mu X, Yang Y, Hua X, et al
    Rapid emergence of high-level tigecycline resistance in Escherichia coli strains harbouring blaNDM-5 in vivo.
    Int J Antimicrob Agents. 2016;47:324-7.
    PubMed     Text format     Abstract available


    March 2016
  94. SUN Q, Ba Z, Wu G, Wang W, et al
    Insertion sequence ISRP10 inactivation of the oprD gene in imipenem-resistant Pseudomonas aeruginosa clinical isolates.
    Int J Antimicrob Agents. 2016 Mar 24. pii: S0924-8579(16)30023.
    PubMed     Text format     Abstract available


  95. BROWNE C, Muszbek N, Chapman R, Marsh K, et al
    Comparative healthcare-associated costs of methicillin-resistant Staphylococcus aureus bacteraemia-infective endocarditis treated with either daptomycin or vancomycin.
    Int J Antimicrob Agents. 2016 Mar 19. pii: S0924-8579(16)30021.
    PubMed     Text format     Abstract available


  96. HASSING RJ, Goessens WH, Zeneyedpour L, Sultan S, et al
    Detection of amino acid substitutions in the GyrA protein of fluoroquinolone-resistant typhoidal Salmonella isolates using high-resolution mass spectrometry.
    Int J Antimicrob Agents. 2016 Mar 15. pii: S0924-8579(16)30019.
    PubMed     Text format     Abstract available


  97. CHEN H, Xiong Z, Liu K, Li S, et al
    Transcriptional profiling of the two-component regulatory system VraSR in Staphylococcus aureus with low-level vancomycin resistance.
    Int J Antimicrob Agents. 2016 Mar 12. pii: S0924-8579(16)30016.
    PubMed     Text format     Abstract available


  98. KIM JS, Kim MJ, Kim SJ, Shin E, et al
    First description of CTX-M-3 extended-spectrum beta-lactamase in an outbreak strain of Shiga toxin-producing Escherichia coli O103:H2.
    Int J Antimicrob Agents. 2016;47:244-5.
    PubMed     Text format    


  99. GHOSH H, Doijad S, Bunk B, Falgenhauer L, et al
    Detection of translocatable units in a blaCTX-M-15 extended-spectrum beta-lactamase-producing ST131 Escherichia coli isolate using a hybrid sequencing approach.
    Int J Antimicrob Agents. 2016;47:245-7.
    PubMed     Text format    


  100. OUYANG W, Xue H, Chen Y, Gao W, et al
    Clinical characteristics and antimicrobial patterns in complicated intra-abdominal infections: a 6-year epidemiological study in southern China.
    Int J Antimicrob Agents. 2016;47:210-6.
    PubMed     Text format     Abstract available


  101. THANGAMANI S, Mohammad H, Abushahba MF, Sobreira TJ, et al
    Repurposing auranofin for the treatment of cutaneous staphylococcal infections.
    Int J Antimicrob Agents. 2016;47:195-201.
    PubMed     Text format     Abstract available


    February 2016
  102. SYUE LS, Chen YH, Ko WC, Hsueh PR, et al
    New drugs for the treatment of complicated intra-abdominal infections in the era of increasing antimicrobial resistance.
    Int J Antimicrob Agents. 2016 Feb 21. pii: S0924-8579(16)00045.
    PubMed     Text format     Abstract available


  103. JEAN SS, Coombs G, Ling T, Balaji V, et al
    Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010-2013.
    Int J Antimicrob Agents. 2016 Feb 17. pii: S0924-8579(16)00042.
    PubMed     Text format     Abstract available


  104. NI W, Han Y, Zhao J, Wei C, et al
    Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2016;47:107-16.
    PubMed     Text format     Abstract available


    January 2016
  105. OLAITAN AO, Morand S, Rolain JM
    Emergence of colistin-resistant bacteria in humans without colistin usage: a new worry and cause for vigilance.
    Int J Antimicrob Agents. 2016;47:1-3.
    PubMed     Text format     Abstract available


  106. RIOU M, Avrain L, Carbonnelle S, El Garch F, et al
    Increase of efflux-mediated resistance in Pseudomonas aeruginosa during antibiotic treatment in patients suffering from nosocomial pneumonia.
    Int J Antimicrob Agents. 2016;47:77-83.
    PubMed     Text format     Abstract available


  107. ALONSO N, Miro E, Pascual V, Rivera A, et al
    Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates.
    Int J Antimicrob Agents. 2016;47:62-8.
    PubMed     Text format     Abstract available


  108. VESTERGAARD M, Paulander W, Marvig RL, Clasen J, et al
    Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosa.
    Int J Antimicrob Agents. 2016;47:48-55.
    PubMed     Text format     Abstract available


    December 2015
  109. KLEIN S, Nurjadi D, Eigenbrod T, Bode KA, et al
    Evaluation of antibiotic resistance to orally administrable antibiotics in staphylococcal bone and joint infections in one of the largest university hospitals in Germany: is there a role for fusidic acid?
    Int J Antimicrob Agents. 2015 Dec 21. pii: S0924-8579(15)00405.
    PubMed     Text format     Abstract available


  110. THAMLIKITKUL V, Tiengrim S, Seenama C
    Comparative in vitro activity of minocycline and selected antibiotics against carbapenem-resistant Acinetobacter baumannii from Thailand.
    Int J Antimicrob Agents. 2015 Dec 11. pii: S0924-8579(15)00397.
    PubMed     Text format    


  111. SCHMITZ RP, Rissner F, Brunkhorst FM
    The Thuringian registry for bloodstream infections, antibiotic resistance and the practice of blood culture sampling-AlertsNet.
    Int J Antimicrob Agents. 2015;46 Suppl 1:S5-9.
    PubMed     Text format     Abstract available


    November 2015
  112. STREEKSTRA H, Keuter A, Wilms L
    Reaction to Dalhoff and Levy: 'Does use of the polyene natamycin as a food preservative jeopardise the clinical efficacy of amphotericin B? A word of concern'.
    Int J Antimicrob Agents. 2015;46:595-6.
    PubMed     Text format    


  113. DALHOFF A
    Response to the reaction to Dalhoff and Levy: 'Does use of the polyene natamycin as a food preservative jeopardise the clinical efficacy of amphotericin B? A word of concern'.
    Int J Antimicrob Agents. 2015;46:596-7.
    PubMed     Text format    


    September 2015
  114. OLAITAN AO, Rolain JM
    Interruption of mgrB in the mediation of colistin resistance in Klebsiella oxytoca.
    Int J Antimicrob Agents. 2015;46:354-5.
    PubMed     Text format    


    July 2015
  115. JAYOL A, Poirel L, Villegas MV, Nordmann P, et al
    Modulation of mgrB gene expression as a source of colistin resistance in Klebsiella oxytoca.
    Int J Antimicrob Agents. 2015;46:108-10.
    PubMed     Text format     Abstract available


  116. SADER HS, Castanheira M, Flamm RK, Mendes RE, et al
    Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia.
    Int J Antimicrob Agents. 2015;46:53-9.
    PubMed     Text format     Abstract available


  117. DE KNEGT GJ, Bakker-Woudenberg IA, van Soolingen D, Aarnoutse R, et al
    SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model.
    Int J Antimicrob Agents. 2015;46:66-72.
    PubMed     Text format     Abstract available


  118. ANK N, Sydenham TV, Iversen LH, Justesen US, et al
    Characterisation of a multidrug-resistant Bacteroides fragilis isolate recovered from blood of a patient in Denmark using whole-genome sequencing.
    Int J Antimicrob Agents. 2015;46:117-20.
    PubMed     Text format     Abstract available


  119. ZHOU L, Yang L, Zeng X, Danzheng J, et al
    Transcriptional and proteomic analyses of two-component response regulators in multidrug-resistant Mycobacterium tuberculosis.
    Int J Antimicrob Agents. 2015;46:73-81.
    PubMed     Text format     Abstract available


  120. VIVAS M, Force E, Tubau F, El Haj C, et al
    Effect of dexamethasone on the efficacy of daptomycin in the therapy of experimental pneumococcal meningitis.
    Int J Antimicrob Agents. 2015;46:28-32.
    PubMed     Text format     Abstract available


    June 2015
  121. DALHOFF AA, Levy SB
    Does use of the polyene natamycin as a food preservative jeopardise the clinical efficacy of amphotericin B? A word of concern.
    Int J Antimicrob Agents. 2015;45:564-7.
    PubMed     Text format     Abstract available


  122. POTRON A, Poirel L, Nordmann P
    Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.
    Int J Antimicrob Agents. 2015;45:568-85.
    PubMed     Text format     Abstract available


  123. ZENTENO-CUEVAS R, Xochihua-Gonzalez O, Cuevas-Cordoba B, Victoria-Cota NL, et al
    Mutations conferring resistance to first- and second-line drugs in multidrug-resistant Mycobacterium tuberculosis clinical isolates in southeast Mexico.
    Int J Antimicrob Agents. 2015;45:671-3.
    PubMed     Text format    


  124. MOURAO J, Novais C, Machado J, Peixe L, et al
    Metal tolerance in emerging clinically relevant multidrug-resistant Salmonella enterica serotype 4,[5],12:i:- clones circulating in Europe.
    Int J Antimicrob Agents. 2015;45:610-6.
    PubMed     Text format     Abstract available


  125. LO HJ, Tseng KY, Kao YY, Tsao MY, et al
    Cph1p negatively regulates MDR1 involved in drug resistance in Candida albicans.
    Int J Antimicrob Agents. 2015;45:617-21.
    PubMed     Text format     Abstract available


  126. VOURLI S, Frantzeskaki F, Meletiadis J, Stournara L, et al
    Synergistic interactions between colistin and meropenem against extensively drug-resistant and pandrug-resistant Acinetobacter baumannii isolated from ICU patients.
    Int J Antimicrob Agents. 2015;45:670-1.
    PubMed     Text format    


  127. OLAITAN AO, Dia NM, Gautret P, Benkouiten S, et al
    Acquisition of extended-spectrum cephalosporin- and colistin-resistant Salmonella enterica subsp. enterica serotype Newport by pilgrims during Hajj.
    Int J Antimicrob Agents. 2015;45:600-4.
    PubMed     Text format     Abstract available


  128. WANG X, Chen H, Zhang Y, Wang Q, et al
    Genetic characterisation of clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline: Role of the global regulator RamA and its local repressor RamR.
    Int J Antimicrob Agents. 2015;45:635-40.
    PubMed     Text format     Abstract available


    May 2015
  129. FALAGAS ME, Vardakas KZ, Kapaskelis A, Triarides NA, et al
    Tetracyclines for multidrug-resistant Acinetobacter baumannii infections.
    Int J Antimicrob Agents. 2015;45:455-60.
    PubMed     Text format     Abstract available


  130. ZHANG Z, Pang Y, Wang Y, Cohen C, et al
    Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China.
    Int J Antimicrob Agents. 2015;45:491-5.
    PubMed     Text format     Abstract available


  131. SAIPROM N, Amornchai P, Wuthiekanun V, Day NP, et al
    Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand.
    Int J Antimicrob Agents. 2015;45:557-9.
    PubMed     Text format    


  132. DOUKA E, Perivolioti E, Kraniotaki E, Fountoulis K, et al
    Emergence of a pandrug-resistant VIM-1-producing Providencia stuartii clonal strain causing an outbreak in a Greek intensive care unit.
    Int J Antimicrob Agents. 2015;45:533-6.
    PubMed     Text format     Abstract available


  133. SOLOMENNYI A, Goncharov A, Zueva L
    Extensively drug-resistant Acinetobacter baumannii belonging to the international clonal lineage I in a Russian burn intensive care unit.
    Int J Antimicrob Agents. 2015;45:525-8.
    PubMed     Text format     Abstract available


  134. SCHINDLER BD, Jacinto PL, Buensalido JA, Seo SM, et al
    Clonal relatedness is a predictor of spontaneous multidrug efflux pump gene overexpression in Staphylococcus aureus.
    Int J Antimicrob Agents. 2015;45:464-70.
    PubMed     Text format     Abstract available


    April 2015
  135. GONZALO X, Casali N, Broda A, Pardieu C, et al
    Combination of amikacin and doxycycline against multidrug-resistant and extensively drug-resistant tuberculosis.
    Int J Antimicrob Agents. 2015;45:406-12.
    PubMed     Text format     Abstract available


  136. GOPAL P, Dick T
    The new tuberculosis drug Perchlozone(R) shows cross-resistance with thiacetazone.
    Int J Antimicrob Agents. 2015;45:430-3.
    PubMed     Text format     Abstract available


  137. AL-MARZOOQ F, Ngeow YF, Tay ST
    Emergence of Klebsiella pneumoniae producing dual carbapenemases (NDM-1 and OXA-232) and 16S rRNA methylase (armA) isolated from a Malaysian patient returning from India.
    Int J Antimicrob Agents. 2015;45:445-6.
    PubMed     Text format    


  138. MACHAIRAS N, Pistiki A, Droggiti DI, Georgitsi M, et al
    Pre-treatment with probiotics prolongs survival after experimental infection by multidrug-resistant Pseudomonas aeruginosa in rodents: an effect on sepsis-induced immunosuppression.
    Int J Antimicrob Agents. 2015;45:376-84.
    PubMed     Text format     Abstract available


  139. LAFEUILLE E, Laouira S, Sougakoff W, Soulier-Escrihuela O, et al
    Detection of OXA-48-like carbapenemase genes by the Xpert(R) Carba-R test: room for improvement.
    Int J Antimicrob Agents. 2015;45:441-2.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: